FDA / 2019

Vyleesi prescribing information

Vyleesi prescribing information — U.S. FDA (2019), cited in PeptideAgent's PT-141 / Bremelanotide evidence record.

Open original source

SOURCE METADATA

What this record represents.

Publisher
U.S. FDA
Evidence type
FDA
Publication year
2019
Source ID
fda-vyleesi-label

WHERE THIS IS CITED

Connected evidence records.

PT-141 / BremelanotideMelanocortin receptor agonist · Sexual Health